[Extrasystole in the intranatal electrocardiogram].

M. Wunderlich

Zentralblatt für Gynäkologie

Abstract:

What problem does this paper attempt to address?

Transcristal Conduction During Isthmus Ablation of Typical Atrial Flutter:

F. Anselme,A. Savouré,S. Ouali,A. Cribier,N. Saoudi

DOI: https://doi.org/10.1046/j.1540-8167.2004.03430.x

2004-02-01

Abstract:The crista terminalis (CT) has been recognized as the anatomic structure responsible for the line of conduction block at the posterior right atrial wall during typical atrial flutter.1 It is now well established that this line of block is mainly functional.2-4 Transverse conduction across the CT can be observed at long pacing cycle length or during some atrial arrhythmias, such as lower loop reentrant tachycardia.5 During typical atrial flutter ablation, determination of complete clockwise isthmus block most often is based on the recording of a purely craniocaudal activation sequence at the anteroinferior right atrium (AIRA) while pacing the proximal coronary sinus (pCS).6,7 However, rapid transverse conduction across the CT can modify the activation sequence at the AIRA and masquerade as persistent residual clockwise isthmus conduction.4 The aims of this study were to evaluate (1) the incidence of transverse conduction across the CT, (2) the influence of transcristal conduction on AIRA activation sequence during pCS pacing after isthmus block,completion and (3) the effectiveness of a dynamic pacing technique (positional pacing) in discriminating anterior from posterior low right atrial conduction properties during typical atrial flutter ablation.
Interference of fetal hemoglobin with the spectrophotometric measurement of carboxyhemoglobin.

H. Vreman,R. B. Ronquillo,R. Ariagno,H. Schwartz,D. Stevenson

DOI: https://doi.org/10.1093/CLINCHEM/34.5.975

IF: 12.114

1988-05-01

Clinical Chemistry

Abstract:We measured the concentration of carboxyhemoglobin (HbCO) in blood samples from 32 neonates by spectrophotometry (IL282 CO-Oximeter) and gas chromatography, finding a strong positive correlation (r = 0.89) between the concentration of fetal hemoglobin (Hb F) and HbCO as measured by spectrophotometry, but not by gas chromatography. Thus, Hb F interferes with the determination of HbCO by spectrophotometric techniques by falsely increasing apparent HbCO in direct proportion to Hb F. We conclude that, when Hb F is known or suspected to be present, blood HbCO cannot be reliably determined by methods based on spectrophotometry.
The Efficacy of Low-Titer Group O Whole Blood Compared With Component Therapy in Civilian Trauma Patients: A Meta-Analysis

Katrina M Morgan,Elissa Abou Khalil,Erin V Feeney,Philip C Spinella,Amelia C Lucisano,Barbara A Gaines,Christine M Leeper,Katrina M. Morgan,Erin V. Feeney,Philip C. Spinella,Amelia C. Lucisano,Barbara A. Gaines,Christine M. Leeper

DOI: https://doi.org/10.1097/ccm.0000000000006244

IF: 8.8

2024-03-14

Critical Care Medicine

Abstract:Objectives: To assess if transfusion with low-titer group O whole blood (LTOWB) is associated with improved early and/or late survival compared with component blood product therapy (CT) in bleeding trauma patients. Data Sources: A systematic search of PubMed, CINAHL, and Web of Science was performed from their inception through December 1, 2023. Key terms included injury, hemorrhage, bleeding, blood transfusion, and whole blood. Study Selection: All studies comparing outcomes in injured civilian adults and children who received LTOWB versus CT were included. Data Extraction: Data including author, publication year, sample size, total blood volumes, and clinical outcomes were extracted from each article and reported following the Meta-analysis Of Observational Studies in Epidemiology guidelines. Main outcomes were 24-hour (early) and combined 28-day, 30-day, and in-hospital (late) mortality rates between recipients of LTOWB versus CT, which were pooled using random-effects models. Data Synthesis: Of 1297 studies reviewed, 24 were appropriate for analysis. Total subjects numbered 58,717 of whom 5,164 received LTOWB. Eleven studies included adults-only, seven included both adults and adolescents, and six only included children. The median (interquartile range) age for patients who received LTOWB and CT was 35 years (24–39) and 35.5 years (23–39), respectively. Overall, 14 studies reported early mortality and 22 studies reported late mortality. LTOWB was associated with improved 24-hour survival (risk ratios [RRs] [95% CI] = 1.07 [1.03–1.12]) and late (RR [95% CI] = 1.05 [1.01–1.09]) survival compared with component therapy. There was no evidence of small study bias and all studies were graded as a moderate level of bias. Conclusions: These data suggest hemostatic resuscitation with LTOWB compared with CT improves early and late survival outcomes in bleeding civilian trauma patients. The majority of subjects were injured adults; multicenter randomized controlled studies in injured adults and children are underway to confirm these findings.

critical care medicine
Resuscitative practices and the use of low-titer group O whole blood in pediatric trauma

Katrina M Morgan,Christine M Leeper,Mark H Yazer,Philip C Spinella,Barbara A Gaines

DOI: https://doi.org/10.1097/TA.0000000000003801

2023-01-01

Abstract:Increasing rates of penetrating trauma in the United States makes rapid identification of hemorrhagic shock, coagulopathy, and early initiation of balanced resuscitation in injured children of critical importance. Hemorrhagic shock begins early after injury and can be challenging to identify in children, as hypotension is a late sign that a child is on the verge of circulatory collapse and should be aggressively resuscitated. Recent data support shifting away from crystalloid and toward early resuscitation with blood products because of worse coagulopathy and clinical outcomes in injured patients resuscitated with crystalloid. Multicenter studies have found improved survival in injured children who receive balanced resuscitation with higher fresh frozen plasma: red blood cell ratios. Whole blood is an efficient way to achieve balanced resuscitation in critically injured children with limited intravenous access and decreased exposure to multiple donors. Administration of cold-stored, low-titer O-negative whole blood (LTOWB) appears to be safe in adults and children and may be associated with improved survival in children with life-threatening hemorrhage. Many pediatric centers use RhD-negative LTOWB for all female children because of the risk of hemolytic disease of the fetus and newborn (0-6%); however. there is a scarcity of LTOWB compared with the demand. Low risks of hemolytic disease of the fetus and newborn affecting a future pregnancy must be weighed against high mortality rates in delayed blood product administration in children in hemorrhagic shock. Survey studies involving key stakeholder's opinions on pediatric blood transfusion practices are underway. Existing pediatric-specific literature on trauma resuscitation is often limited and underpowered; multicenter prospective studies are urgently needed to define optimal resuscitation products and practices in injured children in an era of increasing penetrating trauma.
Whole blood to total transfusion volume ratio in injured children: A national database analysis

Insiyah Campwala,Ander Dorken-Gallastegi,Philip C. Spinella,Joshua B. Brown,Christine M. Leeper

DOI: https://doi.org/10.1097/ta.0000000000004443

2024-09-14

Journal of Trauma and Acute Care Surgery

Abstract:Whole blood (WB) resuscitation is increasingly common in adult trauma centers and some pediatric trauma centers, as studies have noted its safety and potential superiority to component therapy (CT). Previous analyses have evaluated WB as a binary variable (any versus none), and little is known regarding the "dose response" of WB in relation to total transfusion volume (TTV) (WB/TTV ratio).

surgery,critical care medicine
Eating Disorders and Reproduction

J. Morgan

DOI: https://doi.org/10.1111/j.1479-828X.1999.tb03364.x

1999-05-01

Australian and New Zealand Journal of Obstetrics and Gynaecology

Abstract:Summary: Eating disorders are common and characteristically affect young women at what would otherwise be their peak of reproductive functioning. Anorexia nervosa and bulimia nervosa impinge on reproduction both behaviourally and physiologically, with effects on menstruation, ovarian function, fertility, sexuality and pregnancy. This review presents a summary of current knowledge and makes suggestions for future research, along with some clinical recommendations for the management of eating disorders in pregnancy.
Mechanism Matters: Differential benefits of cold-stored whole blood for trauma resuscitation from a prospective multicenter study

Joshua Dilday,Shea Gallagher,Kazuhide Matsushima,Morgan Schellenberg,Kenji Inaba,Joshua P. Hazelton,John Oh,Jennifer Gurney,Matthew Martin,the EAST Whole Blood Multicenter Collaborative

DOI: https://doi.org/10.1097/ta.0000000000004353

2024-05-22

Journal of Trauma and Acute Care Surgery

Abstract:BACKGROUND Resuscitation with cold-stored low-titre whole blood (LTOWB) has increased despite the paucity of robust civilian data. Most studies are in predominately blunt trauma and lack analysis of specific subgroups or mechanism of injury. We sought to compare outcomes between patients receiving LTOWB vs. balanced component therapy (BCT) after blunt (BL) and penetrating (PN) trauma. METHODS Secondary analysis of a prospective multicenter study of patients receiving either LTWOB-containing or BCT resuscitation was performed. Patients were grouped by mechanism of injury (BL vs PN). A generalized estimated equations model using inverse probability of treatment weighting was employed. Primary outcome was mortality and secondary outcomes were acute kidney injury, venous thromboembolism, pulmonary complications, and bleeding complications. Additional analyses were performed on non-traumatic brain injury (TBI), severe torso injury, and LTOWB-only resuscitation patients. RESULTS 1617 patients (BL 47% vs PN 54%) were identified; 1175 (73%) of which received LTOWB. PN trauma patients receiving LTOWB demonstrated improved survival compared to BCT (77% vs. 56%; p<0.01). Interval survival was higher at 6 hrs (95% vs. 88%), 12 hrs (93% vs. 80%) and 24 hrs (88% vs. 57%) (all p<0.05). The survival benefit following LTOWB was also seen across PN non-TBI (83% vs. 52%), and severe torso injuries (75% vs. 43%) (all p <0.05). After controlling for age, sex, injury severity, and trauma center, LTWOB was associated with decreased odds of death (OR .31, p<.05) in PN trauma. However, no difference in overall mortality was seen across the BL groups. Both PN and BL patients receiving LTOWB had more frequent AKI compared to BCT (19% vs. 7% and 12% vs 6%, respectively; p<0.05). CONCLUSIONS LTOWB resuscitation was independently associated with decreased mortality following PN trauma, but not BL trauma. Further analysis in BL trauma is required to identify subgroups that may demonstrate survival benefit. LEVEL OF EVIDENCE Therapeutic/Care Management, III

surgery,critical care medicine
A survey of low titer O whole blood use within the trauma quality improvement program registry

Steven G. Schauer,Michael D. April,Andrew D. Fisher,Franklin L. Wright,Julie M. Winkle,Angela R. Wright,Julie A. Rizzo,Todd M. Getz,Susannah E. Nicholson,Mark H. Yazer,Maxwell A Braverman

DOI: https://doi.org/10.1111/trf.17746

2024-02-14

Transfusion

Abstract:Introduction The use of low titer O whole blood (LTOWB) has expanded although it remains unclear how many civilian trauma centers are using LTOWB. Methods We analyzed data on civilian LTOWB recipients in the American College of Surgeons Trauma Quality Improvement Program (TQIP) database 2020–2021. Unique facility keys were used to determine the number of centers that used LTOWB in that period. Results A total of 16,603 patients received LTOWB in the TQIP database between 2020 and 2021; 6600 in 2020, and 10,003 in 2021. The total number of facilities that reported LTOWB use went from 287/779 (37%) in 2020 to 302/795 (38%) in 2021. Between 2020 and 2021, among all level 1–3 designated trauma facilities that report to TQIP LTOWB use increased at level‐1 centers (118 to 129), and level‐2 centers (81 to 86), but decreased in level‐3 facilities (9 to 4). Among pediatric and dual pediatric‐adult designated hospitals there was a decrease in the number of pediatric level‐1 centers (29 to 28) capable of administering LTOWB. Among centers with either single or dual level‐1 trauma center designation with adult centers, the number that administered LTOWB to injured pediatric patients also decreased from 17 to 10, respectively. Conclusions There was an increase in the number of facilities transfusing LTOWB between 2020 and 2021. The use of LTOWB is underutilized in children at centers that have it available. These findings inform the expansion of LTOWB use in trauma.

hematology
Safety profile of low-titer group O whole blood in pediatric patients with massive hemorrhage

Katrina M Morgan,Mark H Yazer,Darrell J Triulzi,Stephen Strotmeyer,Barbara A Gaines,Christine M Leeper

DOI: https://doi.org/10.1111/trf.16456

Transfusion

Abstract:Background: Low-titer Group O Whole Blood (LTOWB) is used with increasing frequency in adult and pediatric trauma and massive bleeding transfusion protocols. There is a risk of acute hemolytic reactions in non-group O recipients due to the passive transfusion of anti-A and anti-B in the LTOWB. This study investigated the hemolysis risk among pediatric recipients of LTOWB. Study design and methods: Blood bank records were queried for pediatric recipients of LTOWB between June 2016 and August 2020 and merged with clinical data. The primary outcome was laboratory evidence of hemolysis as manifested by changes in lactate dehydrogenase (LDH), haptoglobin, total bilirubin, reticulocyte count, potassium, and creatinine. Per protocol, these values were collected on hospital days 0-2 for recipients of LTOWB. Transfusion reactions were reported to the hospital's blood bank. Results: Forty-seven children received LTOWB transfusion between 2016 and 2020; 21 were group O and 26 were non-group O. The groups were comparable in terms of the total volume of transfused blood products, demographics, and clinical outcomes. The most common indication for LTOWB transfusion was hemorrhagic shock due to trauma. There were no clinically or statistically significant differences in baseline, post-transfusion day 1, or post-transfusion day 2 hemolysis markers between the group O and non-group O LTOWB recipients. There were no adverse events or transfusion reactions reported. Discussion: Use of up to 40 ml/kg of LTOWB appears to be serologically safe for children in hemorrhagic shock.
Use of low titer O whole blood in infants and young children undergoing cardiac surgery with cardiopulmonary bypass

Massimo Griselli,Sameh M. Said,Philip C. Spinella,Michael Evans,Claudia S. Cohn,Nitasha Joyner,Martina Richtsfeld,Kayla Fahey‐Arndt,Julie Welbig,Greg Beilman,Nicole D. Zantek,Marie E. Steiner

DOI: https://doi.org/10.1111/trf.18014

2024-09-14

Transfusion

Abstract:Background Low titer group O whole blood (LTOWB) is commonly used for severe bleeding in trauma patients. LTOWB may also benefit young children requiring cardiac surgery with cardiopulmonary bypass (CPB) at risk of severe bleeding. Study Design and Methods In this retrospective study, children <2 years old who underwent cardiac surgery with CPB were included. Comparisons were performed between those receiving component therapy (CT) versus those receiving LTOWB plus CT (LTOWB+CT). Outcomes included drainage tube (DT) output and total transfusion volumes. Optimization‐based weighting was used for adjusted analyses between groups. Results There were 117 patients transfused with only CT and 127 patients transfused with LTOWB+CT. In the LTOWB+CT group, 66 were Group non‐O and 61 were Group O. Total transfusion volumes given from the start of the operation until the first 24 h in the cardiac intensive care unit was a median (IQR) 41 (10, 93) mL/kg in the CT group and 48 (28, 77) mL/kg in the LTOWB+CT group, (p = .28). Median (IQR) DT output was 22 (15–32) in CT versus 22 (16–28) in LTOWB+CT groups, (p = .27). There were no differences in death, renal failure and a composite of death and renal failure between the two groups, but there were statistically fewer re‐explorations for bleeding in the LTOWB+CT group (p

hematology
Whole Blood Program: Implementation in a Rural Trauma Center

Lanny C Orr,Alexa L Peterson,Tessa C Savell,Elizabeth L McCotter,Craig E Palm,Sadie L Arnold,Gordon M Riha,Simon J Thompson

DOI: https://doi.org/10.1097/JTN.0000000000000810

Abstract:Background: The balanced transfusion of blood components plays a leading role in traumatic hemostatic resuscitation. Yet, previous whole blood studies have only focused on urban trauma center settings. Objective: To compare component vs whole blood therapy on wastage rates and mortality in the rural setting. Methods: This study was a nonrandomized, retrospective, observational, single-center study on a cold-stored whole blood program implementation for adult massive transfusions from 2020 to 2022 at a Level II trauma center. Trauma registry data determined the facility's whole blood needs and facilitated sustainable blood supplies. Whole blood use protocols were established, and utilization and laboratory compliance for incompatible ABO antibody hemolysis was monitored and reviewed monthly at stakeholder and trauma services meetings. Results: From 2018 to 2019, the facility initiated component therapy massive transfusions every 9 days (n = 41). Therefore, four units of low-titer, O-positive whole blood delivered fortnightly was determined to provide patient coverage and minimize wastage. Across the study time frame (2020-2022), there were n = 68 hemodynamically unstable patients, consisting of those receiving whole blood, n = 37, and patients receiving component therapy, n = 31. Mortality rates were significantly lower (p = .030) in the whole blood population (n = 3, 8%) compared to those solely receiving component therapy (n = 9, 29%). Wastage rates were constantly evaluated; in 2021, 43.4% was not utilized, and in 2022, this was reduced to 38.7%. Anecdotally, nurses appreciated the ease of administration and documentation of transfusing whole blood, as it negated ratio compliance. Conclusion: This evidence-based whole blood program provides vital care to severely injured trauma patients in a vast, rural region.
Finding The Sweet Spot: The Association Between Whole Blood To Red Blood Cells Ratio And Outcomes Of Hemorrhaging Civilian Trauma Patients

Hamidreza Hosseinpour,Collin Stewart,Omar Hejazi,Stanley E. Okosun,Muhammad Haris Khurshid,Adam Nelson,Sai Krishna Bhogadi,Michael Ditillo,Louis J. Magnotti,Bellal Joseph

DOI: https://doi.org/10.1097/shk.0000000000002405

2024-09-02

Shock

Abstract:Purpose: To evaluate the dose-dependent effect of whole blood (WB) on the outcomes of civilian trauma patients with hemorrhagic shock. Methods: We performed a 2-year (2020–2021) retrospective analysis of the ACS-TQIP dataset. Adult (≥18) trauma patients with a shock index (SI) >1 who received at least 5 units of PRBC and one unit of WB within the first 4 h of admission were included. Primary outcomes were 6-h, 24-h, and in-hospital mortality. Secondary outcomes were major complications and hospital and intensive care unit length of stay. Results: A total of 830 trauma patients with a mean (SD) age of 38 (16) were identified. The median [IQR] 4-h WB and PRBC requirements were 2 [2–4] U and 10 [7–15] U, respectively, with a median WB:RBC ratio of 0.2 [0.1–0.3]. Every 0.1 increase in WB:RBC ratio was associated with decreased odds of 24-h mortality (aOR: 0.916, P = 0.035) and in-hospital mortality (aOR: 0.878, P < 0.001). Youden's index identified 0.25 (1 U of WB for every 4 U of PRBC) as the optimal WB:PRBC ratio to reduce 24-h mortality. High ratio (≥0.25) group had lower adjusted odds of 24-h mortality (aOR: 0.678, P = 0.021) and in-hospital mortality (aOR: 0.618, P < 0.001) compared to the low ratio group. Conclusions: A higher WB:PRBC ratio was associated with improved early and late mortality in trauma patients with hemorrhagic shock. Given the availability of WB in trauma centers across the United States, at least one unit of WB for every 4 units of packed red blood cells may be administered to improve the survival of hemorrhaging civilian trauma patients.

surgery,peripheral vascular disease,hematology,critical care medicine
Quantifying the benefit of whole blood on mortality in trauma patients requiring emergent laparotomy

Daniel Lammers,Richard Betzold,John McClellan,Matthew Eckert,Jason Bingham,Parker Hu,Stuart Hurst,Emily Baird,Zain Hashmi,Jeffrey Kerby,Jan O. Jansen,John B. Holcomb

DOI: https://doi.org/10.1097/ta.0000000000004382

2024-05-02

Journal of Trauma and Acute Care Surgery

Abstract:Whole blood (WB) transfusions in trauma represent an increasingly utilized resuscitation strategy in trauma patients. Previous reports suggest a probable mortality benefit with incorporating WB into massive transfusion protocols. However, questions surrounding optimal WB practices persist. We sought to assess the association between the proportion of WB transfused during the initial resuscitative period and its impact on early mortality outcomes for traumatically injured patients.

surgery,critical care medicine
Whole blood transfusion versus component therapy in trauma resuscitation: a systematic review and meta‐analysis

Ellen Crowe,Stacia M. DeSantis,Austin Bonnette,Jan O. Jansen,Jose‐Miguel Yamal,John B. Holcomb,Claudia Pedroza,John A. Harvin,Marisa B. Marques,Elenir B.C. Avritscher,Henry E. Wang

DOI: https://doi.org/10.1002/emp2.12089

2020-05-29

Journal of the American College of Emergency Physicians Open

Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Patients with hemorrhagic shock from trauma often require balanced blood product transfusion with red blood cells, plasma, and platelets. Resuscitation with whole blood resuscitation is becoming a common practice. We performed a systematic review and meta‐analysis of studies comparing whole blood transfusion with balanced component therapy in patients suffering from traumatic hemorrhagic shock.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>We searched MEDLINE Ovid, EMBASE, and the Cochrane Library for human studies comparing whole blood with component blood therapy published from January 2007 to June 2019. We included studies from both civilian and military settings and that reported 24‐hour, in‐hospital, or 30‐day mortality. We followed the Preferred Reporting Items in Systematic Reviews and Meta‐Analyses (PRISMA) guidelines, assessing study quality, publication bias, and heterogeneity. We used meta‐analytic models to determine the associations (odds ratio [OR] with 95% confidence interval [CI]) between whole blood transfusion and (1) 24‐hour mortality, and (2) in‐hospital or 30‐day mortality.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>A total of 1759 identified studies, 12 (reporting on n = 8431 patients) met inclusion criteria. There was heterogeneity in the design, setting, interventions, and outcomes of the studies. On meta‐analysis, whole blood transfusion was not associated with 24‐hour mortality (OR = 0.83; 95% CI = 0.56–1.24) or in‐hospital/30‐day mortality (OR = 0.79; 95% CI = 0.48–1.31).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>In this systematic review and meta‐analysis, compared with conventional component transfusion, whole blood was not associated with 24‐hour or in‐hospital mortality. However, there were important limitations with and heterogeneity among the primary studies. Additional study is needed to determine the effectiveness of whole blood.</p></section>
Timing to First Whole Blood Transfusion and Survival Following Severe Hemorrhage in Trauma Patients

Crisanto M. Torres,Kelly M. Kenzik,Noelle N. Saillant,Dane R. Scantling,Sabrina E. Sanchez,Tejal S. Brahmbhatt,Tracey A. Dechert,Joseph V. Sakran

DOI: https://doi.org/10.1001/jamasurg.2023.7178

2024-01-31

JAMA Surgery

Abstract:Importance Civilian trauma centers have revived interest in whole-blood (WB) resuscitation for patients with life-threatening bleeding. However, there remains insufficient evidence that the timing of WB transfusion when given as an adjunct to a massive transfusion protocol (MTP) is associated with a difference in patient survival outcome. Objective To evaluate whether earlier timing of first WB transfusion is associated with improved survival at 24 hours and 30 days for adult trauma patients presenting with severe hemorrhage. Design, Setting, and Participants This retrospective cohort study used the American College of Surgeons Trauma Quality Improvement Program databank from January 1, 2019, to December 31, 2020, for adult patients presenting to US and Canadian adult civilian level 1 and 2 trauma centers with systolic blood pressure less than 90 mm Hg, with shock index greater than 1, and requiring MTP who received a WB transfusion within the first 24 hours of emergency department (ED) arrival. Patients with burns, prehospital cardiac arrest, deaths within 1 hour of ED arrival, and interfacility transfers were excluded. Data were analyzed from January 3 to October 2, 2023. Exposure Patients who received WB as an adjunct to MTP (earlier) compared with patients who had yet to receive WB as part of MTP (later) at any given time point within 24 hours of ED arrival. Main Outcomes and Measures Primary outcomes were survival at 24 hours and 30 days. Results A total of 1394 patients met the inclusion criteria (1155 male [83%]; median age, 39 years [IQR, 25-51 years]). The study cohort included profoundly injured patients (median Injury Severity Score, 27 [IQR, 17-35]). A survival curve demonstrated a difference in survival within 1 hour of ED presentation and WB transfusion. Whole blood transfusion as an adjunct to MTP given earlier compared with later at each time point was associated with improved survival at 24 hours (adjusted hazard ratio, 0.40; 95% CI, 0.22-0.73; P = .003). Similarly, the survival benefit of earlier WB transfusion remained present at 30 days (adjusted hazard ratio, 0.32; 95% CI, 0.22-0.45; P &lt; .001). Conclusions and Relevance In this cohort study, receipt of a WB transfusion earlier at any time point within the first 24 hours of ED arrival was associated with improved survival in patients presenting with severe hemorrhage. The survival benefit was noted shortly after transfusion. The findings of this study are clinically important as the earlier timing of WB administration may offer a survival advantage in actively hemorrhaging patients requiring MTP.

surgery
Maternal and child life years gained by transfusing low titer group O whole blood in trauma: A computer simulation

Mark H. Yazer,Christine Leeper,Philip C. Spinella,Stephen P. Emery,Sarah Horvath,Jansen N. Seheult

DOI: https://doi.org/10.1111/trf.17767

2024-02-27

Transfusion

Abstract:Background Using low titer group O whole blood (LTOWB) is increasingly popular for resuscitating trauma patients. LTOWB is often RhD‐positive, which might cause D‐alloimmunization and hemolytic disease of the fetus and newborn (HDFN) if transfused to RhD‐negative females of childbearing potential (FCP). This simulation determined the number of life years gained by the FCP and her future children if she was resuscitated with LTOWB compared with conventional component therapy (CCT). Methods The model simulated 500,000 injured FCPs of each age between 0 and 49 years with LTOWB mortality relative reductions (MRRs) compared with components between 0.1% and 25%. For each surviving FCP, number of life years gained was calculated using her age at injury and average life expectancy for American women. The number of expected future pregnancies for FCPs that did not survive was also based on her age at injury; each future child was assigned the maximum lifespan unless they suffered perinatal mortality or serious neurological events from HDFN. Results The LTOWB group with an MRR 25% compared with CCT had the largest total life years gained. The point of equivalence for RhD‐positive LTOWB compared to CCT, where life years lost due to severe HDFN was equivalent to life years gained due to FCP survival/future childbearing, occurred at an MRR of approximately 0.1%. Conclusion In this model, RhD‐positive LTOWB resulted in substantial gains in maternal and child life years compared with CCT. A >0.1% relative mortality reduction from LTOWB offset the life years lost to HDFN mortality and severe neurological events.

hematology
Smoking amongst university students in Uganda--an analysis of prevalence and attitudes.

O. Arya,F. J. Bennett

East African Medical Journal

Abstract:
Prevalence and Outcomes of High versus Low Ratio Plasma to Red Blood Cell Resuscitation in a Multi-Institutional Cohort of Severely Injured Children

Steven C Mehl,Adam M Vogel,Amy E Glasgow,Suzanne Moody,Meera Kotagal,Regan F Williams,Mark L Kayton,Emily C Alberto,Randall S Burd,Thomas J Schroeppel,Joanne E Baerg,Amanda Munoz,William B Rothstein,Laura A Boomer,Eric M Campion,Caitlin Robinson,Rachel M Nygaard,Chad J Richardson,Denise I Garcia,Christian J Streck,Michaela Gaffley,John K Petty,Cynthia Greenwell,Samir Pandya,Alicia M Waters,Robert T Russell,Brian K Yorkgitis,Jennifer Mull,Jeffrey Pence,Matthew T Santore,Taleen A MacArthur,Denise B Klinkner,Shawn D Safford,Tanya Trevilian,Megan Cunningham,Christa Black,Jessica Rea,Ryan G Spurrier,Aaron R Jensen,Bethany J Farr,David P Mooney,Bavana Ketha,Melvin S Dassinger,Anna Goldenberg-Sandau,Janika San Roman,Todd M Jenkins,Richard A Falcone,Stephanie F Polites,Steven C. Mehl,Adam M. Vogel,Amy E. Glasgow,Regan F. Williams,Mark L. Kayton,Emily C. Alberto,Randall S. Burd,Thomas J. Schroeppel,Joanne E. Baerg,William B. Rothstein,Laura A. Boomer,Eric M. Campion,Rachel M. Nygaard,Chad J. Richardson,Denise I. Garcia,Christian J. Streck,John K. Petty,Alicia M. Waters,Robert T. Russell,Brian K. Yorkgitis,Matthew T. Santore,Taleen A. MacArthur,Denise B. Klinkner,Shawn D. Safford,Ryan G. Spurrier,Aaron R. Jensen,Bethany J. Farr,David P. Mooney,Melvin S. Dassinger,Todd M. Jenkins,Richard A. Falcone,Stephanie F. Polites

DOI: https://doi.org/10.1097/ta.0000000000004301

2024-03-20

Journal of Trauma and Acute Care Surgery

Abstract:The benefit of targeting high ratio fresh frozen plasma (FFP):red blood cell (RBC) transfusion in pediatric trauma resuscitation is unclear as existing studies are limited to patients who retrospectively met criteria for massive transfusion. The purpose of this study is to evaluate the use of high ratio FFP:RBC transfusion and the association with outcomes in children presenting in shock.

surgery,critical care medicine
Type-specific whole blood still has a role in the era of low titer O universal donor transfusion for severe trauma hemorrhage

Elissa M. Milford,Jennifer M. Gurney,Andrew Beckett,Geir Strandenes,Michael C. Reade

DOI: https://doi.org/10.1097/ta.0000000000004369

2024-05-22

Journal of Trauma and Acute Care Surgery

Abstract:Whole blood can be ABO-type specific (TSWB) or Low-Titer O universal donor (LTOWB). Having previously used LTOWB, the US Armed Forces Blood Program began using TSWB in 1965 as a method of increasing the donor pool. In contrast to military practice, the AABB (Association for the Advancement of Blood and Biotherapies), from its first guidelines in 1958 until 2018, permitted only TSWB. Attempting to reduce time to transfusion, the US military reintroduced LTOWB in the deployed environment in 2015; this practice was endorsed by the AABB in 2018 and is progressively being implemented by military and civilian providers worldwide. LTOWB is the only practical solution prehospital. However, there are several reasons to retain the option of TSWB in hospitals with a laboratory. These include 1. as-yet ill-defined risks of immunological complications from ABO-incompatible plasma (even when this has low titres of anti A and B); 2. risks of high volumes of LTOWB including published historical advice (based on clinical experience) not to transfuse type-specific blood for 2-3 weeks following a substantial LTOWB transfusion; 3. uncertainty as to the optimal definition of "low titre"; and 4. expanding the potential donor pool by allowing type-specific transfusion. Several large randomised controlled trials currently underway are comparing LTOWB to component therapy, but none address the question of LTOWB vs. TSWB. There is sufficient data to suggest the additional risks of transfusing LTOWB to non-group O recipients should be avoided by using TSWB as soon as possible. Combined with the advantage of maintaining an adequate supply of blood products in times of high demand, this suggests retaining TSWB within the civilian and military blood supply system is desirable. TSWB should be preferred when patient blood group is confirmed in facilities with a hematology laboratory, with LTOWB reserved for patients whose blood group is unknown.

surgery,critical care medicine
Whole blood versus balanced resuscitation in massive hemorrhage: six of one or half dozen of the other?

Cassie A. Barton,Heath J. Oetken,Nicolas L. Hall,Michael Kolesnikov,Elizabeth S. Levins,Thomas Sutton,Martin Schreiber

DOI: https://doi.org/10.1097/ta.0000000000004366

2024-05-01

Journal of Trauma and Acute Care Surgery

Abstract:Whole blood (WB) resuscitation is increasingly used at trauma centers. Prior studies investigating outcomes in WB versus component-only (CO) resuscitation have been limited by small cohorts, low volumes of WB resuscitation, and unbalanced CO resuscitation. This study aimed to address these limitations using data from a high-volume Level I trauma center, which adopted a WB-first resuscitation paradigm in 2018. We hypothesized that the resuscitation method, WB or balanced CO, would have no impact on patient mortality.

surgery,critical care medicine

[Extrasystole in the intranatal electrocardiogram].

Transcristal Conduction During Isthmus Ablation of Typical Atrial Flutter:

Interference of fetal hemoglobin with the spectrophotometric measurement of carboxyhemoglobin.

The Efficacy of Low-Titer Group O Whole Blood Compared With Component Therapy in Civilian Trauma Patients: A Meta-Analysis

Resuscitative practices and the use of low-titer group O whole blood in pediatric trauma

Whole blood to total transfusion volume ratio in injured children: A national database analysis

Eating Disorders and Reproduction

Mechanism Matters: Differential benefits of cold-stored whole blood for trauma resuscitation from a prospective multicenter study

A survey of low titer O whole blood use within the trauma quality improvement program registry

Safety profile of low-titer group O whole blood in pediatric patients with massive hemorrhage

Use of low titer O whole blood in infants and young children undergoing cardiac surgery with cardiopulmonary bypass

Whole Blood Program: Implementation in a Rural Trauma Center

Finding The Sweet Spot: The Association Between Whole Blood To Red Blood Cells Ratio And Outcomes Of Hemorrhaging Civilian Trauma Patients

Quantifying the benefit of whole blood on mortality in trauma patients requiring emergent laparotomy

Whole blood transfusion versus component therapy in trauma resuscitation: a systematic review and meta‐analysis

Timing to First Whole Blood Transfusion and Survival Following Severe Hemorrhage in Trauma Patients

Maternal and child life years gained by transfusing low titer group O whole blood in trauma: A computer simulation

Smoking amongst university students in Uganda--an analysis of prevalence and attitudes.

Prevalence and Outcomes of High versus Low Ratio Plasma to Red Blood Cell Resuscitation in a Multi-Institutional Cohort of Severely Injured Children

Type-specific whole blood still has a role in the era of low titer O universal donor transfusion for severe trauma hemorrhage

Whole blood versus balanced resuscitation in massive hemorrhage: six of one or half dozen of the other?